Colorectal Cancer

Watch our video to learn more about the Xilis MOS platform and how it selects the optimal therapy choice for each individual patient.

MicroOrganoSpheresTM (MOS) can be used in Colorectal Cancer. Studies are being conducted now to assess the ability to generate MOSĀ from advanced colon and rectal tumors and perform a drug screen of therapy candidates in <14 days. This will allow for the validation of a diagnostic which can be rapidly used in the clinic to guide therapy for advanced stage patients.

Click figure to enlarge